British journal of cancer (Br J Cancer)

Journal PubWeight™ 21665.38‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. 1977 53.23
2 Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. 1972 35.74
3 Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. 1976 22.55
4 Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. 1957 21.59
5 The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. 2004 12.35
6 The age distribution of cancer and a multi-stage theory of carcinogenesis. 1954 11.33
7 The histological structure of some human lung cancers and the possible implications for radiotherapy. 1955 10.49
8 The spread of rectal cancer and its effect on prognosis. 1958 10.06
9 EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. 1999 9.68
10 Cancer of the stomach in the large towns of England and Wales, 1921-39. 1950 8.77
11 Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. 2003 8.01
12 The benzpyrene content of town air. 1952 7.94
13 A prognostic index in primary breast cancer. 1982 7.35
14 A study of the age curve for cancer of the stomach in connection with a theory of the cancer producing mechanism. 1953 7.04
15 Guidelines for the welfare and use of animals in cancer research. 2010 6.97
16 Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. 1999 6.76
17 Polycyclic hydrocarbons in cigarette smoke. 1954 6.76
18 High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. 2006 6.59
19 A new theory on cancer-inducing mechanism. 1953 6.53
20 3:4-Benzpyrene and other polycyclic hydrocarbons in cigarette smoke. 1955 6.50
21 Studies on mouse leukaemia. The role of the thymus in leukaemogenesis by cell-free leukaemic filtrates. 1960 6.40
22 Who should measure quality of life, the doctor or the patient? 1988 6.32
23 The European mesothelioma epidemic. 1999 6.28
24 What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. 1987 6.20
25 Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. 2005 6.06
26 Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. 2002 5.83
27 A note on geographical variations in cancer mortality, with special reference to gastric cancer in Wales. 1951 5.69
28 A note on competing risks in survival data analysis. 2004 5.60
29 Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. 2001 5.58
30 Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. 1977 5.58
31 The effects of the inhalation of asbestos in rats. 1974 5.57
32 Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. 1999 5.47
33 Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. 2007 5.38
34 MicroRNAs in cell proliferation, cell death, and tumorigenesis. 2006 5.37
35 Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. 2001 5.36
36 Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. 1990 5.34
37 A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. 1957 5.27
38 Allocation of patients to treatment groups in a controlled clinical study. 1978 5.25
39 SOR: project methodology. 2001 5.24
40 Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. 1996 5.24
41 Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. 2009 5.10
42 COSMIC 2005. 2006 5.07
43 Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. 1995 4.99
44 The carcinogenic properties of 2-amino-1-naphthol hydrochloride and its parent amine 2-naphthylamine. 1952 4.97
45 A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. 2000 4.96
46 The clinical course of bone metastases from breast cancer. 1987 4.93
47 Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. 2006 4.93
48 Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison. 1982 4.90
49 The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. 1968 4.88
50 Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. 1966 4.85
Next 50